Deloitte March 30, 2021

Perspectives

How pharma and medtech can shift from doing digital to being digital

Digital transformation is no longer a buzzword—it’s a strategic imperative. Life Science companies should tackle enterprise-wide digital transformation head-on with a holistic, business-driven approach.

Digital transformation: A new competitive imperative

A convergence of events— COVID-19, the acceleration of digital health, economic uncertainty, ecosystem collaboration, and new competition—has impacted life sciences by both accelerating and advancing digital initiatives already underway, and it has jump-started future initiatives. Companies that understand the impact of these events also understand that to thrive, they should change the way they approach digital transformation.

In an...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Digital Health, Health IT, Pharma / Biotech, Technology
Halozyme Pulls €2B Acquisition Bid as Evotec Commits to Standalone Strategy
More than half of US adults could benefit from GLP-1 medications, researchers find
RNA editing is the next frontier in gene therapy—here's what you need to know
Rand roadblock: Biotech bill’s uncertain future
How Digital Chemistry Will Improve Cross-Functional Collaboration In The Biopharma Industry

Share This Article